|
KOREA LIFE SCIENCE
|
GWBIOTEC
|
nonclinical study
|
B55
|
|
KOREA LAB Autumn
|
Hansung Instruments Co,. Ltd
|
Weighing and Measuring Instruments
|
F32
|
|
PARTNERING
|
HAPLNSCIENCE
|
We are developing disease-modifying therapies that leverage recombinant human HAPLN1 (rhHAPLN1)a protein with tissue-regenerative and rejuvenating activity?to fundamentally treat chronic obstructive pulmonary disease (COPD) and osteoarthritis (OA). Our COPD candidate (HS-401) targets emphysema-associated disease and is designed to regenerate lung tissue and restore pulmonary function; the preclinical program has been completed. This program pursues what has long been considered unattainable: a curative approach to COPD. Our osteoarthritis candidate (HS-101) is intended to achieve true disease modification by repairing and structurally restoring cartilage, synovium, and subchondral bone; most preclinical studies have now been completed.
|
E41/H60
|
|
KOREA LAB Autumn
|
Human Corporation
|
Water purification system, UV/VIS spectrophotometer, TOC meter, washing machine, osmometer, foodlab, auto colony counter, lab blender, 99-384 well plate liquid handling workstation, IR-dryer, Aw meter, Chemical balance etc.
|
H25
|
|
NextRegenX
|
Humanase Co., Ltd.
|
Organs-on-Chips
|
B21
|
|
KOREA LIFE SCIENCE
|
HYUNDAI MICRO CO., LTD.
|
BIO/LAB Plasticware, Industrial Filtration
|
E22
|
|
KOREA LIFE SCIENCE
|
I&CP Corp.
|
Data Integrity Forum, Computer Software Assurance, Computer System Validation
|
F51
|
|
KOREA LIFE SCIENCE
|
IKA KOREA Ltd.
|
Bioreactors, Stirrers, Thermoshakers, Pipettes
|
E31
|
|
PARTNERING
|
ILAB
|
Development of a First-in-Class Oral Drug for Immune-Mediated Diseases Addressing the Limitations of Biopharmaceuticals
|
E41
|
|
PARTNERING
|
iMEDIKERS Co., Ltd.
|
Liquid-Based Cytology, LBC
|
A60/H60
|
KYUNGYON EXHIBITION CORP.